AKT1 and neoplasm: At the core of this is the activation of the MAPKs and the PI3K/Akt pathways, recognised for their critical input into initiating tumour metabolic reprogramming, fostering the Warburg effect, processes related to metastasis, disease progression, and the development of resistance to therapeutic interventions in breast tumours [12,13].